Business Wire

Dental Monitoring Partners with Vitruvian to Accelerate Global Expansion of Its Innovative AI Solutions

Del

Dental Monitoring (“DM”), provider of the premier suite of Artificial Intelligence solutions in dentistry and orthodontics, has closed a funding round of €45 million, backed by leading growth investor Vitruvian Partners, to accelerate its global expansion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190311005396/en/

(Photo: Dental Monitoring)

(Photo: Dental Monitoring)

Philippe SALAH, CEO of Dental Monitoring, said: "At Dental Monitoring, we believe that the dental ecosystem can greatly benefit from our technology. We are proud to partner with Vitruvian, as their deep industry expertise and international, growth-driven approach will help us achieve our shared ambition of making Dental Monitoring accessible to all dental stakeholders: patients, doctors, manufacturers, institutions and insurance companies across the world.”

Founded in France in 2015, Dental Monitoring was one of the first companies to recognise how AI could transform the dental profession, and to build a highly sophisticated AI platform protected by over 80 patents. In a world where patients of all ages are expecting technology to change their experience for the better, Dental Monitoring made it its mission to help dental professionals offer better care and more convenience, with tools patients are excited to use: 73% of Millennials would like their doctor to give them an app to manage their care1 and 70% of Baby Boomers are excited about the potential of AI to allow doctors to focus on their health2.

All Dental Monitoring solutions are app or cloud-based, and allow dental professionals to assess and monitor dental conditions, including orthodontics, in-practice or remotely. Their aim is to increase the level of care through the use of sophisticated assessment tools, to augment patient engagement through facilitated communication, and to increase both patient convenience and practice efficiency.

Dental Monitoring will use the funds to accelerate its development in the US and Asia and to strengthen its offering for the global market of general dentists with sophisticated AI-driven solutions.

Torsten Winkler, Partner at Vitruvian Partners, said: "Dental Monitoring is a truly disruptive AI-powered oral care solution, and has shown remarkable performance in substantially growing its user base and executing on an exciting product roadmap for the overall dentistry market. We are excited to partner with Philippe and his team and provide all the support we can to enable Dental Monitoring to achieve global leadership in AI-based services in dental care.”

In 2018, Dental Monitoring partnered with the Straumann Group, a global leader in esthetic dentistry, significantly expanding its reach to dentists around the world. At the IDS in Cologne, the Straumann Group will launch three new additional products that have been developed by DM, including:

  • a new ScanBox to accurately and easily capture intraoral pictures from monitored patients;
  • a solution to produce an instant and automatic pre-assessment of patients’ oral conditions; and
  • a solution to generate photo realistic simulations of the patient’s smile during and after treatment.

Ends.

About Dental Monitoring (www.dental-monitoring.com)
Founded in 2015 by Philippe Salah, Dental Monitoring is the first AI-based company to target dental professionals’ needs. The DM software suite is designed to address the needs of dental professionals all along the patient journey: before treatment to increase the patient’s engagement, during treatment to increase the quality of care provided by the doctor, and after treatment to ensure the stability of the treatment outcome. The company currently operates in Europe, the United States and Asia. It employs a team of about 150 employees across its 4 offices located in Paris, Austin and, Hong Kong and Sydney.

About Vitruvian Partners (www.vitruvianpartners.com)
Vitruvian is an independent growth capital firm which specializes in ‘dynamic situations’ - investments in companies undergoing significant growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Notable investments to date include global market leaders in their field such as Just Eat, Skyscanner as well as life science and AI innovators such as CRF Health, ADA Health, Darktrace and others.

The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of approximately €5 billion. Vitruvian has offices in London, Munich, Stockholm, Luxembourg, San Francisco and Shanghai.

1 Source : 2015 State of the Connected Patient, Salesforce survey of 1,700 US adults
2 Source : 2017 Connected Patient Report, Salesforce survey of 2,083 US adults

Contact information

Press:
Alexe Espiand
Senior Brand and Content Manager, Dental Monitoring
+33 (0)1 88 32 19 65
a.espiand@dental-monitoring.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development21.3.2019 13:44:00 CETPressemelding

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture. The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts. The s

XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 13:27:00 CETPressemelding

Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel

Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 13:17:00 CETPressemelding

BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 13:09:00 CETPressemelding

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi

Workiva Wins DevOps Excellence Award in London21.3.2019 13:03:00 CETPressemelding

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate21.3.2019 11:30:00 CETPressemelding

Teleflex Incorporated (NYSE:TFX) today announced that multiple studies were presented at the 2019 European Association of Urology (EAU) meeting in Barcelona, Spain, highlighting the effectiveness of the UroLift® System, a minimally invasive treatment, usually performed in-office that provides rapid relief and recovery from the symptoms of benign prostatic hyperplasia (BPH).1,2 BPH, also known as enlarged prostate, is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life.3 BPH affects over 40 million men in the United States alone.4 If left untreated, the condition can worsen over time and cause permanent bladder damage.5 A presentation entitled Pulling The Foley: Can the Prostatic Urethral Lift be used in men with catheter-dependent urinary retention? was presented by Thomas Mueller, M.D., urologist of New Jersey Urology (Voorhees, N.J.). The study highlighted real-world retrospective d